Trendlines Group (SG:42T) has released an update.
Trendlines Group has announced significant developments, including the dissolution of its Ag Innovation Fund with Bayer and an investigation into potential fund misappropriations at a Singapore subsidiary. Additionally, its portfolio companies are making strides, with Celleste Bio securing $4.5 million to advance their cocoa ingredient production and ZygoFix Ltd. performing its first U.S. surgery after FDA clearance. Sol-Chip Ltd. is also expanding its market presence following a successful pilot in Germany.
For further insights into SG:42T stock, check out TipRanks’ Stock Analysis page.